Literature DB >> 6756939

Accessory function of human tumor cell lines. I. Production of interleukin 1 by the human histiocytic lymphoma cell line U-937.

R Palacios, I Ivhed, P Sideras, K Nilsson, I Sugawara, C Fernandez.   

Abstract

The established human histiocytic lymphoma cell line U-937 spontaneously produced a factor with biological activity similar to that ascribed to interleukin 1 (IL 1). Actually, supernatants from U-937 cells promoted proliferation of thymocytes initiated by concanavalin A (Con A) and replaced the requirement of accessory cells for activation of highly purified circulating T lymphocytes induced by Con A. Phorbol myristate acetate (PMA) significantly increased the titers of the helper factor produced by U-937 cells as compared to that secreted by non-PMA-treated U-937 cells or PMA-stimulated P388D1 murine macrophage tumor cells. Generally U-937 cells did not secrete detectable IL 1 activity during the first 24-48 h of culture. However, after this initial period the level of IL 1 activity increased and reached a maximum at 5-6 days of culture. Finally, the helper factor released by U-937 cells had an apparent mol. wt. of 12000-15000 as determined by Sephadex G-100 chromatography and lacked interleukin 2 activity as shown by its inability to support growth of IL 2-addicted T cell lines. To our knowledge this is the first report of an established human cell line capable of producing IL 1.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6756939     DOI: 10.1002/eji.1830121018

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Expression of 20 alpha-hydroxysteroid dehydrogenase activity in human lymphoid and non lymphoid cells.

Authors:  A Carbone; M Piantelli; P Musiani; L M Larocca; R P Revoltella; F O Ranelletti
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

2.  BCG-induced suppressor T cells optimal conditions for in vitro induction and mode of action.

Authors:  A S Mustafa; T Godal
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

3.  Characterization of functionally distinct subpopulations of rabbit T lymphocytes.

Authors:  J R Watkins; J M McNicholas; M R Loken; K L Knight
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

4.  Chloride and potassium channels in U937 human monocytes.

Authors:  T Kanno; T Takishima
Journal:  J Membr Biol       Date:  1990-06       Impact factor: 1.843

5.  Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

Authors:  C P Maury; L C Andersson; A M Teppo; S Partanen; E Juvonen
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

6.  Expression of interleukin-1 in Reed-Sternberg cells and neoplastic cells from true histiocytic malignancies.

Authors:  S M Hsu; X Zhao
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

7.  Monoclonal antibodies against human Ia antigens stimulate monocytes to secrete interleukin 1.

Authors:  R Palacios
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Established macrophagelike cell lines synthesize interleukin-1 in response to toxic shock syndrome toxin.

Authors:  A Hirose; T Ikejima; D M Gill
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Biosynthesis of the third component of complement (C3) by the human monocytic-cell line U-937. Induction by phorbol myristate acetate.

Authors:  S Bengio; D Gilbert; P Peulve; M Daveau; M Fontaine
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

10.  Identification and partial characterization of hepatocyte-stimulating factor from leukemia cell lines: comparison with interleukin 1.

Authors:  B M Woloski; G M Fuller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.